Future Leader: Paul Doher, National Director of Clinical Quality, Acorn Health
Impact on your practice
This is a profile piece about a behavioral health leader with no direct policy or regulatory impact on therapists. While Doher's emphasis on quality-driven care aligns with industry values, the article contains no legislative, regulatory, or reimbursement information relevant to practice management.
Key facts
Profile of Paul Doher, National Director of Clinical Quality at Acorn Health
Named 2025 Future Leader by Behavioral Health Business
Advocates for prioritizing quality metrics over operational metrics in behavioral health
Background in special education and transition to behavioral health leadership
Therapy Companion analysis
This profile piece has no direct operational, financial, or regulatory impact on your practice. The subject—Paul Doher, a clinical quality director at a large behavioral health organization—is not announcing policy changes, billing modifications, or compliance requirements that would affect your reimbursement rates, documentation standards, or licensing obligations. You should not expect any change to your prior authorization processes, insurance contracts, or scope of practice based on this article. However, the underlying philosophy Doher articulates—that quality metrics should drive clinical decisions over financial metrics—reflects a broader industry shift worth understanding. If you operate a practice or supervise clinicians, recognize that payers and regulators are increasingly scrutinizing whether providers are prioritizing patient outcomes or revenue optimization. This cultural pressure may eventually translate into stricter quality reporting requirements, more frequent audits of billing practices, and heightened expectations around clinical documentation. For now, this remains aspirational industry commentary rather than enforceable mandate, but the trajectory suggests that practices which can demonstrate measurable quality outcomes (not just billing volume) will fare better in future contracting negotiations.
Background
The behavioral health industry has faced sustained regulatory and reputational damage over the past 18–24 months due to high-profile fraud cases, predatory billing practices, and concerns about corporate consolidation prioritizing profit over patient care. Federal agencies, state boards, and private payers have responded with increased audits, stricter fraud enforcement, and heightened scrutiny of session billing and clinical necessity. Industry leaders like Doher are attempting to reset the conversation around behavioral health as a profession, emphasizing that ethical practice and demonstrable clinical quality are non-negotiable competitive advantages rather than obstacles to profitability. This reflects a recognition that the sector's reputation—and ultimately its sustainability—depends on weeding out bad actors and establishing stronger internal accountability. The appointment of clinically-focused leaders to high-visibility positions in large health systems signals that major organizations are attempting to align operational practices with patient-centered values, though implementation remains inconsistent across the field.
What you should do
Monitor your billing practices and session documentation for evidence of clinical necessity and quality outcomes. If you cannot justify every session billed with specific clinical progress metrics or treatment plan alignment, expect increased scrutiny from payers and regulators in 2025–2026.
If you supervise clinicians or operate a group practice, establish internal quality audits that measure clinical outcomes (symptom reduction, functional improvement, patient satisfaction) alongside productivity and revenue metrics. Document these outcomes in your compliance records.
Review your fee schedules and service offerings. Ensure you are not charging materially higher rates than peer providers in your market for comparable services. Doher's reference to 'exorbitant fees for poor services' signals that payers and regulators will challenge outlier pricing.
Begin tracking and documenting measurable clinical outcomes for your patient population (pre/post-treatment symptom scores, treatment completion rates, patient retention rates). This data will become increasingly important in contract negotiations and regulatory defense.
Stay informed about regulatory enforcement actions in your state and nationally. The article's reference to 'bad actors being called out' indicates heightened federal and state enforcement activity; understanding the pattern of violations will help you avoid similar exposure.
Notable excerpts
"Quality metrics need to drive care more than operational metrics that influence the bottom line. Finances keep the lights on, but if we aren't delivering service with a high level of quality, we're hurting our field." — Paul Doher, National Director of Clinical Quality, Acorn Health
"The industry is being looked at more closely from a regulatory standpoint and a lot of bad actors are being called out for unethical and inappropriate behavior... weeding out the people who are in the industry for the wrong reasons is important." — Paul Doher
Policy changes drive denial patterns
Therapy Companion tracks both: the policy shifts on this page and the denial patterns hitting your claims.
Related policy changes
A New Federal Interpretation Challenges the ‘Gold Standard’ of SMI Care
This DOJ memo could fundamentally reshape where and how community-based mental health services are funded and delivered. Therapists working in community-integrated programs or value-based models should monitor this closely, as it may affect referral patterns, funding models, and scope of practice in community settings.
Behavioral Health Billing Fraud, Kickbacks Totalled $208M in Massive DOJ Fraud Bust
This enforcement action underscores heightened scrutiny of behavioral health billing practices, particularly around rapidly-growing modalities like TMS. Therapists and practices should audit billing accuracy and documentation, especially in high-fraud areas. Overly aggressive billing practices or inadequate supervision documentation now carry real federal prosecution risk.
Advancing the Future of Behavioral Health Data Exchange
Better behavioral health data exchange is a regulatory and operational priority that will likely drive new EHR interoperability requirements and documentation standards for therapists. Understanding this movement helps practices anticipate compliance changes.
STAT+: Trump’s boosting of psychedelics, cannabis signal a new era in GOP drug policy
Federal marijuana rescheduling will complicate assessment, treatment planning, and documentation for therapists, particularly around substance use evaluation and dual diagnoses. Therapists in legal marijuana states will need updated clinical guidelines and liability coverage clarity.